Francisco Partners is acquiring healthcare data and analytics assets from IBM.
Clinical Trials Labeling and Regulated Content Management Added to Cloud-Based Platform
“The deal will help Stryker significantly accelerate [its] digital aspirations to improve the lives of caregivers and patients,” according to company Chair and CEO Kevin Lobo.
The agency is encouraging medical device manufacturers to evaluate their risk and take action to remediate any vulnerability.
For private equity and venture capital investors alike, there are five key trends presenting both headwinds and tailwinds that may impact investment flows into 2022.
The industry association says the shortage has become a serious, industry-wide problem for companies involved in manufacturing medical technologies.
This article reviews real-world examples of product failures, presents reasons for these failures and provides potential solutions better governance, collaboration, and data gathering throughout the product lifecycle.
Digital transformation is especially important to medical device manufacturers because they must have good quality data, and especially tracking metrics, to track complaints and device performance to comply with regulatory requirements. And these requirements are just getting stricter.
MedTech Intelligence recently sat down with Peter O‘Blenis, CEO of Evidence Partners to discuss challenges reviewers face throughout their literature review process in the context of regulatory compliance, and to talk about the upcoming virtual event, Evidence Matters 2021.
To achieve success, a medical device startup must build a sophisticated data architecture specifically designed to deliver maximum value for its customers’ use cases. However, it’s extremely difficult to build such an architecture—especially given early-stage budget constraints. That’s why startups must wisely synch their data architecture spending with their funding rounds.